摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-chlorobenzyl)-N'-cyclohexylthiourea | 345302-92-3

中文名称
——
中文别名
——
英文名称
N-(4-chlorobenzyl)-N'-cyclohexylthiourea
英文别名
1-(4-chlorobenzyl)-3-cyclohexylthiourea;1-[(4-Chlorophenyl)methyl]-3-cyclohexylthiourea
N-(4-chlorobenzyl)-N'-cyclohexylthiourea化学式
CAS
345302-92-3
化学式
C14H19ClN2S
mdl
MFCD02335767
分子量
282.837
InChiKey
XRVFNSGNRHTPDJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    115.5-116 °C
  • 沸点:
    401.6±47.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    56.2
  • 氢给体数:
    2
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    溴丙烷N-(4-chlorobenzyl)-N'-cyclohexylthiourea乙醇 为溶剂, 反应 48.0h, 以43%的产率得到[N-(4-chlorobenzyl)-N'-cyclohexyl-S-propyl]isothiourea hydrobromide
    参考文献:
    名称:
    Development of a Pharmacophore Model for Histamine H3 Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE
    摘要:
    New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine HQ receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible Hg antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of Ha antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high HE receptor affinity, thereby illustrating how the model can be used in the design of new classes of H-3 antagonists.
    DOI:
    10.1021/jm001109k
  • 作为产物:
    描述:
    异氰环已烷对氯苄胺1,2,3,4,5,6,7,8-八硫杂环辛烷 作用下, 反应 1.0h, 以77%的产率得到N-(4-chlorobenzyl)-N'-cyclohexylthiourea
    参考文献:
    名称:
    异氰化物,脂肪胺和元素硫之间的三组分反应:温和条件下完全硫原子经济的硫脲的制备
    摘要:
    摘要 发现在元素硫存在下,异氰化物与脂肪胺的反应在室温或接近室温的条件下有效进行,以极好的收率和完全的原子经济性生产硫脲。 发现在元素硫存在下,异氰化物与脂肪胺的反应在室温或接近室温的条件下有效进行,以极好的收率和完全的原子经济性生产硫脲。
    DOI:
    10.1055/s-0034-1379327
点击查看最新优质反应信息

文献信息

  • Molecular Determinants of Ligand Binding Modes in the Histamine H<sub>4</sub> Receptor: Linking Ligand-Based Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Models to in Silico Guided Receptor Mutagenesis Studies
    作者:Enade P. Istyastono、Saskia Nijmeijer、Herman D. Lim、Andrea van de Stolpe、Luc Roumen、Albert J. Kooistra、Henry F. Vischer、Iwan J. P. de Esch、Rob Leurs、Chris de Graaf
    DOI:10.1021/jm201042n
    日期:2011.12.8
    pharmacophore features in H4R and its ligands, different alternative ligand binding mode hypotheses have been proposed. The current study focuses on the elucidation of the molecular determinants of H4R–ligand binding modes by combining (3D) quantitative structure–activity relationship (QSAR), protein homology modeling, molecular dynamics simulations, and site-directed mutagenesis studies. We have designed
    组胺H 4受体(H 4 R)是一种G蛋白偶联受体(GPCR),在炎症中起重要作用。与同源组胺H 3受体(H 3 R)相似,H 4 R结合口袋中的两个酸性残基D 3.32和E 5.46充当H 4 R配体中可正电离的氢键供体的必要氢键受体。考虑到这些互补药效基团特征在H 4 R及其配体中的对称分布,提出了不同的替代配体结合模式假说。当前的研究集中在阐明H 4的分子决定因素通过结合(3D)定量结构-活性关系(QSAR),蛋白质同源性建模,分子动力学模拟和定点诱变研究,实现R-配体结合模式。我们设计并合成了一系列clobenpropit(N-(4-氯苄基)-S- [3-(4(5)-咪唑基)丙基]异硫脲)衍生物,以研究H 4 R-配体相互作用和配体结合方向。有趣的是,我们的研究表明clobenpropit(2)本身可以以两种不同的结合模式结合H 4 R,而在clobenpropit isothiou
  • Three-Component Reaction between Isocyanides, Aliphatic Amines and Elemental Sulfur: Preparation of Thioureas under Mild Conditions with Complete­ Atom Economy
    作者:Thanh Nguyen、Ali Al-Mourabit、Ludmila Ermolenko
    DOI:10.1055/s-0034-1379327
    日期:——
    Abstract The reaction of isocyanides with aliphatic amines in the presence of elemental sulfur was found to proceed efficiently at, or near, room temperature to produce thioureas in excellent yields and with complete atom economy. The reaction of isocyanides with aliphatic amines in the presence of elemental sulfur was found to proceed efficiently at, or near, room temperature to produce thioureas in excellent
    摘要 发现在元素硫存在下,异氰化物与脂肪胺的反应在室温或接近室温的条件下有效进行,以极好的收率和完全的原子经济性生产硫脲。 发现在元素硫存在下,异氰化物与脂肪胺的反应在室温或接近室温的条件下有效进行,以极好的收率和完全的原子经济性生产硫脲。
  • Development of a Pharmacophore Model for Histamine H<sub>3</sub> Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE
    作者:Iwan J. P. De Esch、James E. J. Mills、Tim D. J. Perkins、Giuseppe Romeo、Marcel Hoffmann、Kerstin Wieland、Rob Leurs、Wiro M. P. B. Menge、Paul H. J. Nederkoorn、Philip M. Dean、Henk Timmerman
    DOI:10.1021/jm001109k
    日期:2001.5.1
    New molecular modeling tools were developed to construct a qualitative pharmacophore model for histamine HQ receptor antagonists. The program SLATE superposes ligands assuming optimum hydrogen bond geometry. One or two ligands are allowed to flex in the procedure, thereby enabling the determination of the bioactive conformation of flexible Hg antagonists. In the derived model, four hydrogen-bonding site points and two hydrophobic pockets available for binding antagonists are revealed. The model results in a better understanding of the structure-activity relationships of Ha antagonists. To validate the model, a series of new antagonists was synthesized. The compounds were designed to interact with all four hydrogen-bonding site points and the two hydrophobic pockets simultaneously. These ligands have high HE receptor affinity, thereby illustrating how the model can be used in the design of new classes of H-3 antagonists.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐